<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 16 Sep 2026 18:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING</title>
   <link>http://www.streetinsider.com/Press+Releases/COSCIENS+COMPLETES+SECOND+TRANCHE+OF+CONVERTIBLE+DEBENTURE+OFFERING/27071317.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;b&gt;TORONTO, ONTARIO, Sept.  16, 2026  (GLOBE NEWSWIRE) -- &lt;/b&gt;COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“&lt;b&gt;COSCIENS&lt;/b&gt;” or the “&lt;b&gt;Company&lt;/b&gt;”) is pleased to announce, further to the press release dated September 10, 2026, the closing of the second tranche of a non-brokered private placement of the 15% unsecured convertible debentures (the “&lt;b&gt;Offering&lt;/b&gt;”).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;In the second tranche of the Offering, the Company issued additional unsecured convertible debentures (the “&lt;b&gt;Debentures&lt;/b&gt;”) in an aggregate principal amount of US$4,375,000 million, for an aggregate principal amount, together with the first closing, of US$10,706,250. The terms of the Offering contemplate the issuance</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/COSCIENS+COMPLETES+SECOND+TRANCHE+OF+CONVERTIBLE+DEBENTURE+OFFERING/27071317.html</guid>
   <pubDate>Wed, 16 Sep 2026 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	  </item>
  <item>
   <title>COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING</title>
   <link>http://www.streetinsider.com/Globe+Newswire/COSCIENS+COMPLETES+SECOND+TRANCHE+OF+CONVERTIBLE+DEBENTURE+OFFERING/27071317.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;b&gt;TORONTO, ONTARIO, Sept.  16, 2026  (GLOBE NEWSWIRE) -- &lt;/b&gt;COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“&lt;b&gt;COSCIENS&lt;/b&gt;” or the “&lt;b&gt;Company&lt;/b&gt;”) is pleased to announce, further to the press release dated September 10, 2026, the closing of the second tranche of a non-brokered private placement of the 15% unsecured convertible debentures (the “&lt;b&gt;Offering&lt;/b&gt;”).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;In the second tranche of the Offering, the Company issued additional unsecured convertible debentures (the “&lt;b&gt;Debentures&lt;/b&gt;”) in an aggregate principal amount of US$4,375,000 million, for an aggregate principal amount, together with the first closing, of US$10,706,250. The terms of the Offering contemplate the issuance</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/COSCIENS+COMPLETES+SECOND+TRANCHE+OF+CONVERTIBLE+DEBENTURE+OFFERING/27071317.html</guid>
   <pubDate>Wed, 16 Sep 2026 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	  </item>
  <item>
   <title>Cosciens acquires Nualtis for up to $15M in cash deal</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Cosciens+acquires+Nualtis+for+up+to+%2415M+in+cash+deal/27048600.html</link>
   <description>

&lt;p&gt;Cosciens Biopharma Inc. (TSX: CSCI, OTCQB: CSCIF) has acquired Nualtis Corp., a Montreal-based specialty pharmaceutical company focused on oral thin-film drug delivery technologies, for a cash purchase price of US$15 million, subject to customary adjustments and potential earn-out payments.&lt;/p&gt;

&lt;p&gt;Under the terms of the share purchase agreement with seller AtaiBeckley Inc., Cosciens made an initial payment of US$9 million at closing, with the remaining US$6 million due as a deferred payment within six months. Additional earn-out payments of up to 10% of Nualtis' adjusted EBITDA may be payable for fiscal years 2027 through 2030.&lt;/p&gt;

&lt;p&gt;Nualtis, formerly known as IntelGenx Corp. and established</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Cosciens+acquires+Nualtis+for+up+to+%2415M+in+cash+deal/27048600.html</guid>
   <pubDate>Thu, 10 Sep 2026 16:15:19 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	  </item>
  <item>
   <title>COSCIENS ACQUIRES NUALTIS CORP.</title>
   <link>http://www.streetinsider.com/Press+Releases/COSCIENS+ACQUIRES+NUALTIS+CORP./27048577.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TORONTO, ONTARIO, Sept.  10, 2026  (GLOBE NEWSWIRE) -- &lt;/strong&gt;COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“&lt;b&gt;COSCIENS&lt;/b&gt;” or the “&lt;b&gt;Company&lt;/b&gt;”) is pleased to announce the acquisition of Nualtis Corp. (“&lt;b&gt;Nualtis&lt;/b&gt;”), a Montreal-based specialty pharmaceutical technology business focused primarily on proprietary oral thin-film drug delivery technologies, with applications for both human and animal health. The Company also announced the completion of the first tranche of a non-brokered private placement of unsecured convertible debentures.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;&lt;u&gt;ACQUISITION HIGHLIGHTS:&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;b&gt;Strategic acquisition of a leading oral thin film (“OTF”) development and manufacturing platform: &lt;/b&gt;&lt;i&gt;Nualtis is an industry leader and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/COSCIENS+ACQUIRES+NUALTIS+CORP./27048577.html</guid>
   <pubDate>Thu, 10 Sep 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	  </item>
  <item>
   <title>COSCIENS ACQUIRES NUALTIS CORP.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/COSCIENS+ACQUIRES+NUALTIS+CORP./27048577.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;TORONTO, ONTARIO, Sept.  10, 2026  (GLOBE NEWSWIRE) -- &lt;/strong&gt;COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“&lt;b&gt;COSCIENS&lt;/b&gt;” or the “&lt;b&gt;Company&lt;/b&gt;”) is pleased to announce the acquisition of Nualtis Corp. (“&lt;b&gt;Nualtis&lt;/b&gt;”), a Montreal-based specialty pharmaceutical technology business focused primarily on proprietary oral thin-film drug delivery technologies, with applications for both human and animal health. The Company also announced the completion of the first tranche of a non-brokered private placement of unsecured convertible debentures.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;b&gt;&lt;u&gt;ACQUISITION HIGHLIGHTS:&lt;/u&gt;&lt;/b&gt;&lt;/p&gt;  &lt;ul type=&quot;disc&quot;&gt;&lt;li style=&quot;text-align:justify;&quot;&gt;&lt;b&gt;Strategic acquisition of a leading oral thin film (“OTF”) development and manufacturing platform: &lt;/b&gt;&lt;i&gt;Nualtis is an industry leader and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/COSCIENS+ACQUIRES+NUALTIS+CORP./27048577.html</guid>
   <pubDate>Thu, 10 Sep 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	  </item>
  <item>
   <title>Form  15-12G     COSCIENS Biopharma Inc.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++COSCIENS+Biopharma+Inc.++++++++++++++/26736004.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26736004.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++COSCIENS+Biopharma+Inc.++++++++++++++/26736004.html</guid>
   <pubDate>Mon, 06 Jul 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  15-12G     COSCIENS Biopharma Inc.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++COSCIENS+Biopharma+Inc.++++++++++++++/26736004.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26736004.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++COSCIENS+Biopharma+Inc.++++++++++++++/26736004.html</guid>
   <pubDate>Mon, 06 Jul 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  15-12G     COSCIENS Biopharma Inc.              </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++COSCIENS+Biopharma+Inc.++++++++++++++/26736004.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26736004.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++COSCIENS+Biopharma+Inc.++++++++++++++/26736004.html</guid>
   <pubDate>Mon, 06 Jul 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26733247.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26733247.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26733247.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26733247.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26733247.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26733247.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26733247.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26733247.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26733247.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jul 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jul+06/26733232.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26733232.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jul+06/26733232.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jul 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jul+06/26733232.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26733232.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jul+06/26733232.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jul 06</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jul+06/26733232.html</link>
   <description>si-local-file:///var/storage/secattach/20260706/26733232.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jul+06/26733232.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jun 22</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+22/26675361.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675361.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+22/26675361.html</guid>
   <pubDate>Tue, 23 Jun 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jun 22</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+22/26675361.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675361.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+22/26675361.html</guid>
   <pubDate>Tue, 23 Jun 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jun 22</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+22/26675361.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675361.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+22/26675361.html</guid>
   <pubDate>Tue, 23 Jun 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26675363.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675363.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26675363.html</guid>
   <pubDate>Tue, 23 Jun 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26675363.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675363.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26675363.html</guid>
   <pubDate>Tue, 23 Jun 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26675363.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26675363.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26675363.html</guid>
   <pubDate>Tue, 23 Jun 2026 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+18/26663827.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26663827.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+18/26663827.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+18/26663827.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26663827.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+18/26663827.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  6-K        COSCIENS Biopharma Inc.   For: Jun 18</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+18/26663827.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26663827.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++COSCIENS+Biopharma+Inc.+++For%3A+Jun+18/26663827.html</guid>
   <pubDate>Thu, 18 Jun 2026 09:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26663328.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26663328.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26663328.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
  <item>
   <title>Form  SC 13E3/A  COSCIENS Biopharma Inc.                Filed by: COSCIENS Biopharma Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26663328.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26663328.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13E3A++COSCIENS+Biopharma+Inc.++++++++++++++++Filed+by%3A+COSCIENS+Biopharma+Inc./26663328.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CSCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CSCIF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00673999</category>
   	  </item>
 </channel>
</rss>
